Detalhe da pesquisa
1.
An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.
NPJ Vaccines
; 8(1): 127, 2023 Aug 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37626082
2.
Defining neutralization and allostery by antibodies against COVID-19 variants.
Nat Commun
; 14(1): 6967, 2023 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37907459
3.
Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2.
Sci Rep
; 13(1): 21810, 2023 12 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38071323
4.
SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.
Elife
; 102021 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33554856
5.
A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies.
Commun Med (Lond)
; 1: 46, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-35602218
6.
Author Correction: An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.
NPJ Vaccines
; 8(1): 136, 2023 Sep 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37749097